USUS News

New Drug for Seriously Ill COVID-19 Patients Shows Promise Under Right to Try Act

Save
New Drug for Seriously Ill COVID-19 Patients Shows Promise Under Right to Try Act
Breathing tubes hang next to a man with COVID-19 on a ventilator at a Stamford Hospital Intensive Care Unit in Stamford, Conn. on April 24, 2020. John Moore/Getty Images
Nanette Holt
Updated:
New information collected under the federal Right to Try Act shows promise for the new drug ZYESAMI, now in clinical trials for the treatment of serious cases of COVID-19.

The information was collected by a hospital in the U.S. southwest, drug developer NRx announced in a news release Jan. 26.

Nanette Holt
Nanette Holt
Senior Features Editor
Nanette Holt is an Epoch Times reporter and senior features editor covering issues of national interest. Ms. Holt has had more than 30 years of experience in media and has written for Reader’s Digest, Woman’s World, the Tampa Tribune, the St. Petersburg Times, and others.
twitter
Related Topics